Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2020 Filed Aug 6, 2020 10:09 UTC |
Leen Ann M.Chief Scientific Officer
|
ConversionSeries A-3 Convertible Preferred Stock · Derivative | 3,631,293 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-021598 · doc4.xml · derivative · entry 3 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 2,436,773 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date. F1 · price: Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date. F2 · ownership.nature: Shares held by Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 10:09 UTC |
Leen Ann M.Chief Scientific Officer
|
ConversionCommon Stock | 2,436,773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-021598 · doc4.xml · nonDerivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,436,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date. F2 · ownership.nature: Shares held by Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:34 UTC |
GADICKE ANSBERTDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020911 · doc4.xml · derivative · entry 1 GADICKE ANSBERT · CIK 0001134655 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) July 29, 2021, and (b) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 18:35 UTC |
Atillasoy ErcemSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 407,400 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020912 · doc4.xml · derivative · entry 2 Atillasoy Ercem · CIK 0001818802 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,400 Underlying: Common Stock · 407,400 shares Expires 2030-07-29 F2 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 20, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 18:35 UTC |
Atillasoy ErcemSee Remarks
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020912 · doc4.xml · nonDerivative · entry 1 Atillasoy Ercem · CIK 0001818802 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on July 20, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. In the event of the Reporting Person's termination without cause or for good reason, the RSUs shall immediately vest in full. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 18:44 UTC |
Melian AgustinChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 220,700 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020933 · doc4.xml · derivative · entry 1 Melian Agustin · CIK 0001818064 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,700 Underlying: Common Stock · 220,700 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 18:39 UTC |
Brainard DianaDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020920 · doc4.xml · derivative · entry 1 Brainard Diana · CIK 0001818070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest and become exercisable in equal quarterly installments over three years, with the first installment vesting on October 29, 2020. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 18:35 UTC |
Brenner MalcolmDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020913 · doc4.xml · derivative · entry 1 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) July 29, 2021, and (b) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:46 UTC |
Hallal DavidDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 1,101,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020935 · doc4.xml · derivative · entry 1 Hallal David · CIK 0001457477 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,000 Underlying: Common Stock · 1,101,000 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:44 UTC |
Jovan-Embiricos MoranaDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020932 · doc4.xml · derivative · entry 1 Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) July 29, 2021, and (b) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:43 UTC |
Leen Ann M.Chief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 257,600 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020931 · doc4.xml · derivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,600 Underlying: Common Stock · 257,600 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:42 UTC |
Bornstein Jeffrey SDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020927 · doc4.xml · derivative · entry 1 Bornstein Jeffrey S · CIK 0001579989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) July 29, 2021, and (b) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:42 UTC |
Miller EdwardGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 200,600 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020926 · doc4.xml · derivative · entry 1 Miller Edward · CIK 0001619252 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,600 Underlying: Common Stock · 200,600 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:40 UTC |
Sinha VikasDirector · See Remarks · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 436,900 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020925 · doc4.xml · derivative · entry 1 Sinha Vikas · CIK 0001337845 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,900 Underlying: Common Stock · 436,900 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:39 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 237,200 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020921 · doc4.xml · derivative · entry 1 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,200 Underlying: Common Stock · 237,200 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:38 UTC |
Wilson John RobertDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020918 · doc4.xml · derivative · entry 1 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) July 29, 2021, and (b) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:38 UTC |
Vera JuanDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020917 · doc4.xml · derivative · entry 1 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-07-29 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) July 29, 2021, and (b) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 22:34 UTC |
Hagen Brett RChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 43,400 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-020910 · doc4.xml · derivative · entry 1 Hagen Brett R · CIK 0001681782 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,400 Underlying: Common Stock · 43,400 shares Expires 2030-07-29 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on July 29, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.